March 16, 2022

Exosomes: A Deeper Look into Service Providers Market

By Aanchal Chaudhary Exosomes 0 Comments

Over the years, applications of exosomes in therapeutics have undergone an evolutionary change, in terms of cost of research, technology used, and duration of the study. Moreover, various startups and small firms have entered into collaborations in order to advance their innovations and offer specialized research expertise, services and technologies. In order to promote the use of exosomes in various therapeutic applications including targeted drug delivery vehicles, engineered exosomes and many more, there are a number of companies that offer services related to the isolation, purification, characterization or quantification of exosomes. Presently, outsourcing of exosome related services has become a popular practice where drug developers are actively outsourcing their operations to specialized repurposed-based service providers, which are known to have the required capabilities and expertise.

Exosome Service Providers – Current Market Landscape

Currently, 48 companies worldwide are actively engaged in offering services related to exosomes with enhanced efficacy. The market is characterized by a mix of well-established and small firms.

Exosomes: A Deeper Look into Service Providers Market

Want additional details on the pipeline?

Recent activity in Partnerships and collaborations

The growing interest in exosome development and manufacturing services market is reflected in the recent increase in partnership activity, especially between companies that offer related to characterization and analytic services.

Published Scientific Literature: Indicative of the Ongoing pace of Research in this Field

Over the years, there has been a gradual increase in the number of publications related to exosomes. Majority of the publications were focused on isolation, characterization and profiling of exosomes.

Broad Clinical Trial Landscape

Till date, over 180 clinical studies which primarily include completed, ongoing and planned trials evaluating various clinical research activity related to exosomes and involving nearly 2,392 patients enrolled across different centers / hospitals, have been initiated worldwide.

High Number of Patents are Suggestive of the Widespread Research in this Domain

The exosomes technologies have seen a significant rise in the number of patents over the past few years, with Moderna leading the way in terms of the total number of patents filed / granted.

Future Evolution of Exosome Development and Manufacturing Services Market

With the rising demand for novel therapeutic modalities, the exosome development and manufacturing services market is anticipated to grow at an annualized rate of 16% between 2022 and 2035.